Simplexia is develops vaccine against herpes simplex virus type (HSV-2) infection, which is the most common sexually transmitted infection in the world. The infection causes genital herpes with painful and recurrent genital blisters. HSV-2 can also cause life-threatening encephalitis and meningitis in newborns and immunocompromised patients. A major issue is that HSV-2 infected patients also suffer a three-fold increased risk of HIV acquisition.
Company Details
- Employees
- 6
- Address
- Nanna Svartz Väg 2, Stockholm,stockholm County 17165,sweden
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- simplexia.se
- Keywords
- SandhanMatrimony.com.
- HQ
- Stockholm, Stockholm County
Simplexia Questions
Simplexia's website is simplexia.se
Simplexia's LinkedIn profile is https://se.linkedin.com/company/simplexia
Simplexia has
6 employees.
View email and phone details for 6
employees at Simplexia.
Simplexia's industry is
Biotechnology Research
Simplexia's top competitors are
Macrocyclics,
Indian Travel Expo,
Metasafe,
Pexa Ab,
Eurocine Vaccines,
Strike Pharma Ab,
1elevan Bio,
Biopromic,
Curovir Ab,
Sandhanmatrimony.com.
Simplexia's categories are Biotechnology Research
